1. Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.
- Author
-
Dehghanian F, Ghahnavieh LE, Nilchi AN, Khalilian S, and Joonbakhsh R
- Subjects
- Female, Humans, Antineoplastic Agents therapeutic use, Antineoplastic Agents pharmacology, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases metabolism, Signal Transduction, Breast Neoplasms drug therapy, Breast Neoplasms metabolism, Breast Neoplasms genetics, Breast Neoplasms pathology, Drug Resistance, Neoplasm genetics, Hippo Signaling Pathway
- Abstract
The most significant factors that lead to cancer-related death in breast cancer (BC) patients include drug resistance, migration, invasion, and metastasis. Several signaling pathways are involved in the development of BC. The different types of BC are initially sensitive to chemotherapy, and drug resistance can occur through multiple molecular mechanisms. Regardless of developing targeted Therapy, due to the heterogenic nature and complexity of drug resistance, it is a major clinical challenge with the low survival rate in BC patients. The deregulation of several signaling pathways, particularly the Hippo pathway (HP), is one of the most recent findings about the molecular mechanisms of drug resistance in BC, which are summarized in this review. Given that HP is one of the recent cancer research hotspots, this review focuses on its implication in BC drug resistance. Unraveling the different molecular basis of HP through its crosstalk with other signaling pathways, and determining the effectiveness of HP inhibitors can provide new insights into possible therapeutic strategies for overcoming chemoresistance in BC., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF